We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
+4.77%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
AUM
$2.9B
AUM Growth
+$137M
Cap. Flow
+$88.8M
Cap. Flow %
3.06%
Top 10 Hldgs %
17.97%
Holding
1,008
New
71
Increased
442
Reduced
400
Closed
82

Sector Composition

Rank Sector Weight
1 Technology 12.53%
2 Healthcare 11.66%
3 Financials 9.01%
4 Industrials 7.22%
5 Consumer Discretionary 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VMEO
1001
DELISTED
Vimeo
VMEO
-15,089
Closed -$117K
VRNA
1002
DELISTED
Verona Pharma
VRNA
-185,819
Closed -$19.8M
VRNT
1003
DELISTED
Verint Systems
VRNT
-53,532
Closed -$1.08M
VTRS icon
1004
Viatris
VTRS
$18.8B
-90,136
Closed -$892K
WAFD icon
1005
WaFd
WAFD
$2.77B
-10,077
Closed -$305K
WFC icon
1006
Wells Fargo
WFC
$264B
-13,750
Closed -$1.15M
WSBC icon
1007
WesBanco
WSBC
$4B
-19,350
Closed -$618K
MRP
1008
Millrose Properties Inc
MRP
$4.86B
-6,975
Closed -$234K

Similar funds

Hennion & Walsh Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, Hennion & Walsh Asset Management held 1,008 positions worth $2.9B, up 5% from $2.76B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Hennion & Walsh Asset Management deployed $88.8M of net new capital in Q4 2025, opening 71 new positions and adding to 442 existing holdings. Its largest new stake was Schwab Fundamental International Large Company Index ETF: 53,014 shares worth $2.4M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Rhythm Pharmaceuticals, an estimated $3.59M trimmed.

  • Hennion & Walsh Asset Management's largest Q4 2025 buy was Schwab Fundamental International Large Company Index ETF: 53,014 shares worth $2.4M.
  • Hennion & Walsh Asset Management added most to Invesco Trust Investment Grade Municipals in Q4 2025, an estimated $4.8M increase.
  • Hennion & Walsh Asset Management's biggest Q4 2025 reduction was Rhythm Pharmaceuticals, cutting an estimated $3.59M.
  • Hennion & Walsh Asset Management fully exited Verona Pharma in Q4 2025, selling an estimated $19.8M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 18% of its $2.9B portfolio in Q4 2025.
  • Hennion & Walsh Asset Management opened 71 new positions and closed 82 in Q4 2025.
  • Hennion & Walsh Asset Management's portfolio value rose 5% quarter-over-quarter to $2.9B.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2025, filed 14 Jan 2026.